RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,972,000 | +67.2% | 331,351 | +0.1% | 0.00% | +100.0% |
| Q2 2016 | $1,777,000 | +33.8% | 330,867 | +14.6% | 0.00% | 0.0% |
| Q1 2016 | $1,328,000 | -10.5% | 288,637 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $1,483,000 | -14.1% | 285,237 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,727,000 | -61.8% | 285,467 | -0.2% | 0.00% | -66.7% |
| Q2 2015 | $4,516,000 | +105.8% | 285,995 | +41.7% | 0.01% | +100.0% |
| Q1 2015 | $2,194,000 | +14.8% | 201,819 | +11.1% | 0.00% | 0.0% |
| Q4 2014 | $1,911,000 | +9.3% | 181,680 | -0.3% | 0.00% | +50.0% |
| Q3 2014 | $1,748,000 | -16.2% | 182,289 | +0.9% | 0.00% | -33.3% |
| Q2 2014 | $2,087,000 | +26.3% | 180,730 | +9.4% | 0.00% | +50.0% |
| Q1 2014 | $1,653,000 | -22.3% | 165,265 | +1.1% | 0.00% | -33.3% |
| Q4 2013 | $2,128,000 | -14.5% | 163,459 | -2.1% | 0.00% | -25.0% |
| Q3 2013 | $2,490,000 | +81.0% | 166,909 | +13.4% | 0.00% | +100.0% |
| Q2 2013 | $1,376,000 | – | 147,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 888,132 | $4,618,000 | 3.71% |
| GREAT POINT PARTNERS LLC | 1,282,527 | $6,669,000 | 2.80% |
| Broadfin Capital, LLC | 2,412,995 | $12,548,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 685,000 | $3,562,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 209,787 | $1,091,000 | 0.29% |
| TFS CAPITAL LLC | 477,884 | $2,485,000 | 0.27% |
| FT Options LLC | 127,400 | $220,000 | 0.16% |
| Tourbillon Capital Partners, L.P. | 1,264,999 | $6,578,000 | 0.15% |
| Birchview Capital, LP | 40,000 | $208,000 | 0.12% |
| SECOR Capital Advisors, LP | 70,111 | $365,000 | 0.10% |